Empagliflozin reduces albuminuria - A promise for better cardiorenal protection from the EMPA-REG OUTCOME trial

Rikke Borg, Frederik Persson^*

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Leder › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	478
Tidsskrift	Annals of Translational Medicine
Vol/bind	5
Udgave nummer	23
DOI	https://doi.org/10.21037/atm.2017.11.02
Status	Udgivet - dec. 2017

Adgang til dokumentet

@article{c52ee94e79874bf88f70cfe778e47da6,

title = "Empagliflozin reduces albuminuria - A promise for better cardiorenal protection from the EMPA-REG OUTCOME trial",

author = "Rikke Borg and Frederik Persson",

year = "2017",

month = dec,

doi = "10.21037/atm.2017.11.02",

language = "English",

volume = "5",

journal = "Annals of Translational Medicine",

issn = "2305-5839",

publisher = "AME Publishing Company",

number = "23",

}

TY - JOUR

T1 - Empagliflozin reduces albuminuria - A promise for better cardiorenal protection from the EMPA-REG OUTCOME trial

AU - Borg, Rikke

AU - Persson, Frederik

PY - 2017/12

Y1 - 2017/12

UR - http://www.scopus.com/inward/record.url?scp=85037161929&partnerID=8YFLogxK

U2 - 10.21037/atm.2017.11.02

DO - 10.21037/atm.2017.11.02

M3 - Editorial

C2 - 29285511

AN - SCOPUS:85037161929

SN - 2305-5839

VL - 5

JO - Annals of Translational Medicine

JF - Annals of Translational Medicine

IS - 23

M1 - 478

ER -